A vida como biocapital - futuros biológicos, uma aposta dos bancos privados de células-tronco de cordão umbilical no brasil

2Citations
Citations of this article
3Readers
Mendeley users who have this article in their library.

Abstract

With the development of contemporary medical biotechnology, health and life are intertwined in a market of care by fear, anticipation, and promotion, only a posteriori in the form of treatments. A posture of fear and persecution, to ensure the future health of the child is not only to provide medical monitoring, because in wait there might exist diseases that were not even named and engendered. To manage life as consumption practices and tradable made proliferate services aimed at ensuring and protecting the uncertainty. In the middle class, next to the proposed health concerns of the newborns, we seek to ensure the usufruct of future uncertain treatments or non-detectable diseases through stem cells private services of collection and storage of the umbilical cord and placental tissue. These banks acquire the means of existence in a neoliberal logic of prevention and precaution based on fear and placement of security mechanisms that act as shields for the increasingly uncertainty around life government.

Cite

CITATION STYLE

APA

Galindo, D., Lemos, F. S., & Rodrigues, R. V. (2014). A vida como biocapital - futuros biológicos, uma aposta dos bancos privados de células-tronco de cordão umbilical no brasil. Athenea Digital, 14(2), 255–274. https://doi.org/10.5565/rev/athenea.1198

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free